In last trading session, Mind Medicine Inc (NASDAQ:MNMD) saw 0.89 million shares changing hands with its beta currently measuring 2.33. Company’s recent per share price level of $6.35 trading at $0.04 or 0.63% at ring of the bell on the day assigns it a market valuation of $478.58M. That closing price of MNMD’s stock is at a discount of -92.44% from its 52-week high price of $12.22 and is indicating a premium of 20.79% from its 52-week low price of $5.03. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.54 million shares which gives us an average trading volume of 2.04 million if we extend that period to 3-months.
For Mind Medicine Inc (MNMD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.09. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Upright in the green during last session for gaining 0.63%, in the last five days MNMD remained trading in the red while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $6.35 price level, adding 6.07% to its value on the day. Mind Medicine Inc’s shares saw a change of -8.76% in year-to-date performance and have moved -7.03% in past 5-day. Mind Medicine Inc (NASDAQ:MNMD) showed a performance of -25.38% in past 30-days. Number of shares sold short was 11.81 million shares which calculate 3.9 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 15 to the stock, which implies a rise of 57.67% to its current value. Analysts have been projecting 14 as a low price target for the stock while placing it at a high target of 16. It follows that stock’s current price would drop -120.47% in reaching the projected high whereas dropping to the targeted low would mean a loss of -120.47% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.11% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -2.36% while estimates for its earnings growth in next 5 years are of 8.04%.
Mind Medicine Inc (NASDAQ:MNMD)’s Major holders
Insiders are in possession of 0.68% of company’s total shares while institution are holding 55.74 percent of that, with stock having share float percentage of 56.12%. Investors also watch the number of corporate investors in a company very closely, which is 55.74% institutions for Mind Medicine Inc that are currently holding shares of the company. COMMODORE CAPITAL LP is the top institutional holder at MNMD for having 7.15 million shares of worth $51.52 million. And as of 2024-06-30, it was holding 9.9369 of the company’s outstanding shares.
The second largest institutional holder is DEEP TRACK CAPITAL, LP, which was holding about 6.1 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.4879 of outstanding shares, having a total worth of $44.01 million.
On the other hand, iShares Russell 2000 ETF and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 2.17 shares of worth $13.75 million or 2.87% of the total outstanding shares. The later fund manager was in possession of 988.95 shares on Dec 31, 2024 , making its stake of worth around $6.28 million in the company or a holder of 1.31% of company’s stock.
